BTIG notes that Bloomberg reported earlier that Buy-rated Paysafe (PSFE) is exploring a sale after receiving takeover interest. The article ...

In a report released today, Marie Thibault from BTIG reiterated a Buy rating on Haemonetics (HAE – Research Report), with a price target of ...

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced its ...

BTIG analyst Clark Lampen adjusted the price target for Roblox Corp . (NYSE:RBLX) shares, raising it to $73 from the previous $66, while maintaining a Buy rating on the stock. The reevaluation ...

BTIG analyst Andrew Harte maintained a Buy rating on Paysafe stock (NYSE:PSFE) with a $26.00 price target. This affirmation came in the wake of reports from Bloomberg that Paysafe is exploring the ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale and orthopedic relationships.

The Trump administration will try to return Fannie Mae and Freddie Mac to the private sector, but it probably won’t happen ...

Each Unit Includes One Class A Ordinary Share and One Share Right to Receive 1/15th of a Class A Ordinary Share ...

CEO Brian Harris emphasized the company's strong liquidity position and preparedness to deploy capital as commercial real estate markets stabilize. He stated that Ladder ended the year with $2.2 ...

CEO David Shaffer highlighted a return to growth, with Q3 revenue increasing 5% year-over-year, supported by contributions from Bren-Tronics and improving U.S. communications market conditions.

BTIG Research lowered shares of IQVIA (NYSE:IQV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat.com reports. Several other ...